Cardiac Arrhythmias 2003
Proceedings of the 8th International Workshop on Cardiac Arrhythmias
(Sprache: Englisch)
The field of cardiac arrhythmias has been evolving so fast during the last years that scientific meetings are frequently necessary to present technological advances, to communicate results of relevant and innovative researches, to assess the impact of...
Leider schon ausverkauft
versandkostenfrei
Buch
203.29 €
101 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Cardiac Arrhythmias 2003 “
Klappentext zu „Cardiac Arrhythmias 2003 “
The field of cardiac arrhythmias has been evolving so fast during the last years that scientific meetings are frequently necessary to present technological advances, to communicate results of relevant and innovative researches, to assess the impact of recently developed diagnostic and therapeutical tools, to discuss controversial aspects, and to reach a consensus on the most appropriate evaluation and management of specific problems. This is the main reason why in 1988 we started to organize a biannual International Workshop on Cardiac Arrhythmias. Since then many editions of the workshop have taken place and over the years the fame and popularity of the event have increased continuously. This book contains the Proceedings of the Eighth Edition of the Workshop th th held in Venice at the Fondazione Giorgio Cini from the 5 to the 8 of October 2003. During the meeting all the principal aspects of the different arrhythmias, from epidemiology to physiopathology, electrogenetic mechanisms, diagnosis, prognosis, treatment, pshycological implications and economic costs have been discussed among the numerous experts and participants.
Inhaltsverzeichnis zu „Cardiac Arrhythmias 2003 “
- Defining anatomic structures: when and why is it important?- Ablation of atrial fibrillation: what are the true advantages?
- Ablation of ventricular tachycardia: may the current results be improved by intracardiac echocardiography?
- Risk stratification and prevention of thromboembolism: which role for intracardiac echocardiography?
- Intracardiac echocardiography: what are the future expectations?
- Legs crossing and muscle tensing to abort vasovagal syncope: a novel effective treatment?
- Isometric arm contraction at the onset of prodromal symptoms: a new first-line treatment for vasovagal syncope?
- Patient-activated implantable drug pump for treatment of vasovagal syncope: is it time for clinical use?
- Hemodynamic assessment with implanted pacemakers: how feasible and reliable is it?
- Hemodynamic sensors: what is the impact in the clinical practice?
- Hemodynamic sensors: can they ensure physiological rate control?
- Trans-valvular Impedance: does it allow automatic capture detection?
- Palpitations of unknown origin: how frequent is a supraventricular tachyarrhythmia as cause?
- Complex supraventricular tachycardias: what is the role of alternative technologies?
- Vasovagal syncope, orthostatic hypotension and POTS: which relationship?
- Distinguishing syncope from seizure: how useful is the clinical history?
- Unexplained syncope: can we predict the outcome of implantable loop recorder?
- What are the perfusion and adrenergic innervation of the left ventricle in paced patients?
- How does left ventricle remodel after long-term single or dual ventricle cardiac pacing?
- Acute termination of atrial flutter: class III drugs or transesophageal pacing?
- Class I C / Amiodarone atrial flutter: what are the long-term results of cavo-tricuspid isthmus ablation?
- Atypical atrial flutter: how to locate and ablate the reentry circuit?
- How to diagnose, locate and ablate coronary cusp ventricular tachycardia?
- Drug-induced torsade de
... mehr
pointe: a fruste form of congenital long QT syndrome?
- Which drug to prefer in the different clinical conditions?
- "Sympathetic" and "vagal" atrial fibrillation: do they exist?
- Predicting atrial fibrillation in hypertension: are we able?
- Is the cause of arrhythmogenic right ventricular cardiomyopathy congenital or acquired?
- Frequent monomorphic right ventricular premature beats: are they an early manifestation of arrhythmogenic right ventricular cardiomyopathy?
- Is ICD implantation useful in patients with arrhythmogenic right ventricular cardiomyopathy?
- New evidence from the secondary endpoints of the MADIT II study.-What is the real economic impact of MADIT II study on the European medical community?
- Diagnosis of neurally mediated syncope: may implantable loop recorder replace tilt table test?
- To pace or not to pace for neurally mediated syncope: do we know the answer?
- Waveform flexibility: will it be the solution for future shocks?
- Sleep apnea: which new insights?
- "Pill" in the pocket strategy for treatment of atrial fibrillation recurrences: how effective and safe is it?
- Cardioversion of recent-onset atrial fibrillation: which drug to prefer in the single patient?
- Pretreatment with antiarrhythmic drugs: is it useful to avoid immediate and early post-cardioversion recurrences?
- Does the policy of repeated early cardioversion for recurrences of atrial fibrillation work?
- Electrical cardioversion of atrial fibrillation: how to improve the outcome?
- What is the prevalence, incidence and prognostic value of Brugada-type electrocardiogram in the general population?
- Brugada syndrome or Brugada mimicry?
- Ventricular tachycardia or conduction disease: what is the mechanism of death in Brugada syndrome?
- What are the keys for the hemodynamic improvement in heart failure patients?
- AV Delay in heart failure pacing: how to manage it?
- Heart failure therapy driven by implantable sensors: what might be expected?
- How to manage atrial fibrillation in patients with congestive heart failure?
- ACE inhibitors and angiotensin receptor blockers: a new effective non conventional approach to prevent atrial fibrillation?
- Wall thickness > 30 mm identifies patients with hypertrophic cardiomyopathy at risk of sudden death
- What is the impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy?
- Alcohol septal ablation is effective in reducing symptoms and risk of sudden death in hypertrophic cardiomyopathy patients.-Rate control of atrial fibrillation: how much should ventricular rate be lowered?
- "Ablate and pace": still a valid option?
- Management of atrial fibrillation: is it already time to update the recent ACC/AHA/ESC guidelines?
- UN Is low EF alone enough to identify high risk patients or do we need additional testing?
- What is the prognostic value of non sustained ventricular tachycardia in patients with no severely depressed ejection fraction?
- Patients with heart failure and RBBB or non specific intraventricular conduction disturbances: can they benefit from ardiac resynchronization therapy?
- Upgrading from right ventricular apical pacing to biventricular pacing: when and how?
- Atrial tachyarrhythmias late after repair of congenital heart disease: which mechanism and how to localize and ablate it?
- Atrial fibrillation after open heart surgery: what's the fuss?
- New-onset ventricular tachyarrhythmias after cardiac surgery: which significance and treatment?
- Late atrial arrhythmic complications after valvular heart surgery: is there a place for prevention?
- Atrial pacing is a useful treatment to prevent atrial fibrillation
- Dual-chamber ICDS: how effective and safe are they in treating atrial tachyarrhythmias?
- Lesson from "LESS" trial: is one ventricular fibrillation induction adeguate for ICD implant?
- Inappropriate defibrillator therapies: do dual-chamber devices really provide a remedy?
- Should antiarrhythmic drugs be administered after first appropriate ICD shock and which agent to prefer?
- Rationale for the study
- Pharmacological therapy: compliance, dosage.-Results and clinical implications of the COMPANION trial
- How large is the patient population, which may benefit?
- Electrophisiologically guided antiarrhythmic surgery for treatment of frequently recurrent ventricular tachycardia: which role today?
- Heart transplantation as last resort in patients with frequently recurrent drug-refractory ventricular tachyarrhythmias: is it worthwhile?
- Surgical revascularization in patients with "ischemia-related" ventricular fibrillation: is it sufficient to prevent sudden death?
- RF and microwave ablation of atrial fibrillation during open heart surgery: which long-term results?
- Minimally invasive surgical approach for RF ablation of atrial fibrillation: is the game worth the candle?
- Which road to choose in cardiac resynchronization therapy: the low voltage or the high voltage road?
- Ablation for atrial fibrillation: are we still "learning while burning"?
- Ablation of atrial fibrillation: is the cure at hand?
- Catheter ablation of atrial fibrillation: what are the risks and complications and how to avoid them?
- Post- infarction patients with low LVEF (= 40% > 30%), non-sustained VT and without inducible tachyarrhythmias: is ICD implantation necessary?
- Post infarction patients with severe LV dysfunction (LVEF < 30%): does EPS have any role in further stratifying the risk of sudden death?
- How to detect and manage pacemaker / ICD failure and infections?
- Pacemaker / ICD lead extraction using the Excimer laser sheath: what are the advantages and what are the risks?
- How to detect and treat superior vena cava obstruction caused by multiple pacing / ICD leads?
- Lead-related thrombi in patients with pacemaker / ICD: what is the prevalence, clinical significance and recommended management?
- What are the most common electromagnetic interferences on implanted pacemaker / ICD and how to avoid them?
- Anatomical-guided is superior to electrophysiological-guided ablation
- Mechanical/surgical revascularization in patients with ventricular fibrillation and coronary artery disease: is it enough or do we need also an ICD?
- Patient with structural heart disease, syncope of unknown origin and inducible ventricular tachyarrhythmias: ICD implantation or "wait and watch" strategy?
- What is the best LV stimulation site for cardiac resynchronization therapy?
- Cardiac resynchronization therapy: is atrial resynchronization important with biventricular pacing?
- Permanent His bundle pacing: a good non conventional right ventricular pacing?
- Secondary prevention of sudden death in post-infarction patients: when ICD implantation is really cost-effective?
- Primary prevention of sudden death in post-infarction patients: when ICD implantation is really cost-effective?
- Cost-effectiveness of ICD implantation in clinical settings different from ischemic heart disease: what do we know?
- Expanding ICD indications: can we afford it?
- Quality of life in patients with ICD: is it improved or worsened?
- How to identify patients most likely to respond to cardiac resynchronization therapy?
- Cardiac resynchronization therapy in patients with atrial fibrillation: are the results as good as in patients with sinus rhythm?
- Impact of cardiac resynchronization therapy on mortality: what do we expect from ongoing trials?
- Laser balloon ablation
- Cryodevices for isolation
- Radio-frequency circular energy delivery
- Public use of automated external defibrillators in Europe: where are we and where are we going?
- Use of automated external defibrillators by lay people in patients with out-of-hospital cardiac arrest: which impact on survival?
- In hospital cardiac arrest: are we sufficiently equipped and prepared to face it?
- Mild therapeutic hypothermia for treatment of cardiac arrest: which current results and future perspectives?
- Which device data do we need for optimal patient treatment?
- What are the benefits of digital pacemaker?
- What is the best practical scheme to initiate oral anticoagulant treatment in outpatients with atrial fibrillation?
- What should be the anticoagulation intensity at the time of cardioversion to reduce the risk of thromboembolism?
- Warfarin underuse for non valvular atrial fibrillation: how to adjust fire?
- Idiopathic ventricular tachycardia: is RF ablation the first choice therapy?
- Is it possible to perform RF ablation of hemodynamically unstable ventricular tachycardia in patients with structural heart disease and how?
- Sinus node dysfunction: a genetic background?
- Remodeling of sinus node function produced by supraventricular tachyarrhythmias: which clinical implications?
- Drug-induced bradyarrhythmia: when is pacemaker warranted?
- Permanent pacing treatment: conventional DDDR, antitachycardia pacing or atrial defibrillator? data do we need for optimal patient treatment?
- What are the benefits of digital pacemaker?
- What is the best practical scheme to initiate oral anticoagulant treatment in outpatients with atrial fibrillation?
- What should be the anticoagulation intensity at the time of cardioversion to reduce the risk of thromboembolism?
- Warfarin underuse for non valvular atrial fibrillation: how to adjust fire?
- Idiopathic ventricular tachycardia: is RF ablati
- Which drug to prefer in the different clinical conditions?
- "Sympathetic" and "vagal" atrial fibrillation: do they exist?
- Predicting atrial fibrillation in hypertension: are we able?
- Is the cause of arrhythmogenic right ventricular cardiomyopathy congenital or acquired?
- Frequent monomorphic right ventricular premature beats: are they an early manifestation of arrhythmogenic right ventricular cardiomyopathy?
- Is ICD implantation useful in patients with arrhythmogenic right ventricular cardiomyopathy?
- New evidence from the secondary endpoints of the MADIT II study.-What is the real economic impact of MADIT II study on the European medical community?
- Diagnosis of neurally mediated syncope: may implantable loop recorder replace tilt table test?
- To pace or not to pace for neurally mediated syncope: do we know the answer?
- Waveform flexibility: will it be the solution for future shocks?
- Sleep apnea: which new insights?
- "Pill" in the pocket strategy for treatment of atrial fibrillation recurrences: how effective and safe is it?
- Cardioversion of recent-onset atrial fibrillation: which drug to prefer in the single patient?
- Pretreatment with antiarrhythmic drugs: is it useful to avoid immediate and early post-cardioversion recurrences?
- Does the policy of repeated early cardioversion for recurrences of atrial fibrillation work?
- Electrical cardioversion of atrial fibrillation: how to improve the outcome?
- What is the prevalence, incidence and prognostic value of Brugada-type electrocardiogram in the general population?
- Brugada syndrome or Brugada mimicry?
- Ventricular tachycardia or conduction disease: what is the mechanism of death in Brugada syndrome?
- What are the keys for the hemodynamic improvement in heart failure patients?
- AV Delay in heart failure pacing: how to manage it?
- Heart failure therapy driven by implantable sensors: what might be expected?
- How to manage atrial fibrillation in patients with congestive heart failure?
- ACE inhibitors and angiotensin receptor blockers: a new effective non conventional approach to prevent atrial fibrillation?
- Wall thickness > 30 mm identifies patients with hypertrophic cardiomyopathy at risk of sudden death
- What is the impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy?
- Alcohol septal ablation is effective in reducing symptoms and risk of sudden death in hypertrophic cardiomyopathy patients.-Rate control of atrial fibrillation: how much should ventricular rate be lowered?
- "Ablate and pace": still a valid option?
- Management of atrial fibrillation: is it already time to update the recent ACC/AHA/ESC guidelines?
- UN Is low EF alone enough to identify high risk patients or do we need additional testing?
- What is the prognostic value of non sustained ventricular tachycardia in patients with no severely depressed ejection fraction?
- Patients with heart failure and RBBB or non specific intraventricular conduction disturbances: can they benefit from ardiac resynchronization therapy?
- Upgrading from right ventricular apical pacing to biventricular pacing: when and how?
- Atrial tachyarrhythmias late after repair of congenital heart disease: which mechanism and how to localize and ablate it?
- Atrial fibrillation after open heart surgery: what's the fuss?
- New-onset ventricular tachyarrhythmias after cardiac surgery: which significance and treatment?
- Late atrial arrhythmic complications after valvular heart surgery: is there a place for prevention?
- Atrial pacing is a useful treatment to prevent atrial fibrillation
- Dual-chamber ICDS: how effective and safe are they in treating atrial tachyarrhythmias?
- Lesson from "LESS" trial: is one ventricular fibrillation induction adeguate for ICD implant?
- Inappropriate defibrillator therapies: do dual-chamber devices really provide a remedy?
- Should antiarrhythmic drugs be administered after first appropriate ICD shock and which agent to prefer?
- Rationale for the study
- Pharmacological therapy: compliance, dosage.-Results and clinical implications of the COMPANION trial
- How large is the patient population, which may benefit?
- Electrophisiologically guided antiarrhythmic surgery for treatment of frequently recurrent ventricular tachycardia: which role today?
- Heart transplantation as last resort in patients with frequently recurrent drug-refractory ventricular tachyarrhythmias: is it worthwhile?
- Surgical revascularization in patients with "ischemia-related" ventricular fibrillation: is it sufficient to prevent sudden death?
- RF and microwave ablation of atrial fibrillation during open heart surgery: which long-term results?
- Minimally invasive surgical approach for RF ablation of atrial fibrillation: is the game worth the candle?
- Which road to choose in cardiac resynchronization therapy: the low voltage or the high voltage road?
- Ablation for atrial fibrillation: are we still "learning while burning"?
- Ablation of atrial fibrillation: is the cure at hand?
- Catheter ablation of atrial fibrillation: what are the risks and complications and how to avoid them?
- Post- infarction patients with low LVEF (= 40% > 30%), non-sustained VT and without inducible tachyarrhythmias: is ICD implantation necessary?
- Post infarction patients with severe LV dysfunction (LVEF < 30%): does EPS have any role in further stratifying the risk of sudden death?
- How to detect and manage pacemaker / ICD failure and infections?
- Pacemaker / ICD lead extraction using the Excimer laser sheath: what are the advantages and what are the risks?
- How to detect and treat superior vena cava obstruction caused by multiple pacing / ICD leads?
- Lead-related thrombi in patients with pacemaker / ICD: what is the prevalence, clinical significance and recommended management?
- What are the most common electromagnetic interferences on implanted pacemaker / ICD and how to avoid them?
- Anatomical-guided is superior to electrophysiological-guided ablation
- Mechanical/surgical revascularization in patients with ventricular fibrillation and coronary artery disease: is it enough or do we need also an ICD?
- Patient with structural heart disease, syncope of unknown origin and inducible ventricular tachyarrhythmias: ICD implantation or "wait and watch" strategy?
- What is the best LV stimulation site for cardiac resynchronization therapy?
- Cardiac resynchronization therapy: is atrial resynchronization important with biventricular pacing?
- Permanent His bundle pacing: a good non conventional right ventricular pacing?
- Secondary prevention of sudden death in post-infarction patients: when ICD implantation is really cost-effective?
- Primary prevention of sudden death in post-infarction patients: when ICD implantation is really cost-effective?
- Cost-effectiveness of ICD implantation in clinical settings different from ischemic heart disease: what do we know?
- Expanding ICD indications: can we afford it?
- Quality of life in patients with ICD: is it improved or worsened?
- How to identify patients most likely to respond to cardiac resynchronization therapy?
- Cardiac resynchronization therapy in patients with atrial fibrillation: are the results as good as in patients with sinus rhythm?
- Impact of cardiac resynchronization therapy on mortality: what do we expect from ongoing trials?
- Laser balloon ablation
- Cryodevices for isolation
- Radio-frequency circular energy delivery
- Public use of automated external defibrillators in Europe: where are we and where are we going?
- Use of automated external defibrillators by lay people in patients with out-of-hospital cardiac arrest: which impact on survival?
- In hospital cardiac arrest: are we sufficiently equipped and prepared to face it?
- Mild therapeutic hypothermia for treatment of cardiac arrest: which current results and future perspectives?
- Which device data do we need for optimal patient treatment?
- What are the benefits of digital pacemaker?
- What is the best practical scheme to initiate oral anticoagulant treatment in outpatients with atrial fibrillation?
- What should be the anticoagulation intensity at the time of cardioversion to reduce the risk of thromboembolism?
- Warfarin underuse for non valvular atrial fibrillation: how to adjust fire?
- Idiopathic ventricular tachycardia: is RF ablation the first choice therapy?
- Is it possible to perform RF ablation of hemodynamically unstable ventricular tachycardia in patients with structural heart disease and how?
- Sinus node dysfunction: a genetic background?
- Remodeling of sinus node function produced by supraventricular tachyarrhythmias: which clinical implications?
- Drug-induced bradyarrhythmia: when is pacemaker warranted?
- Permanent pacing treatment: conventional DDDR, antitachycardia pacing or atrial defibrillator? data do we need for optimal patient treatment?
- What are the benefits of digital pacemaker?
- What is the best practical scheme to initiate oral anticoagulant treatment in outpatients with atrial fibrillation?
- What should be the anticoagulation intensity at the time of cardioversion to reduce the risk of thromboembolism?
- Warfarin underuse for non valvular atrial fibrillation: how to adjust fire?
- Idiopathic ventricular tachycardia: is RF ablati
... weniger
Bibliographische Angaben
- Autor: Antonio Raviele
- 2004, 948 Seiten, Maße: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben: Antonio Raviele
- Verlag: Springer Milan
- ISBN-10: 8847002311
- ISBN-13: 9788847002319
- Erscheinungsdatum: 10.10.2003
Sprache:
Englisch
Kommentar zu "Cardiac Arrhythmias 2003"
0 Gebrauchte Artikel zu „Cardiac Arrhythmias 2003“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Cardiac Arrhythmias 2003".
Kommentar verfassen